Cite

    Coget, E., Laffont-Lozes, P., Velasco Gonzalvo, V., Huc, D., Pineton de Chambrun, G., Altwegg, R., Blanc, P., Pageaux, G., Rosant, D., & Breuker, C. (n.d.). 4CPS-144 Establishment of a pharmaceutical standardised interview concerning biosimilars of infliximab in the daycare clinic of a gastroenterology department for patients affected by inflammatory bowel disease. European journal of hospital pharmacy, 26, A136. http://access.bl.uk/ark:/81055/vdc_100135135994.0x000004